Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery
- Registration Number
- NCT03044808
- Lead Sponsor
- Odense University Hospital
- Brief Summary
Single center double blind randomised controlled trial. 60 subjects. Giving lidocaine IV or saline to patients due to robot assisted colorectal surgery. Primary outcome is cumulative morphine consumption at 24 hours.
- Detailed Description
Prospective double blind randomised controlled trial. The investigators are giving lidocaine IV or saline to 60 patients undergoing robot assisted colorectal surgery. Blinding and randomization is done by the hospital pharmacy. Both groups get otherwise the same treatment and a IV PCA (patient controlled administration) morphine pump for objectivisation of opioid consumption. Other outcome measures are NRS (numerical rating score) pain score, PONV (postoperative nausea and vomiting), use of antiemetics and opioid consumption up to 72 hours.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- all patients due to robotic laparoscopic colorectal surgery, > 18years of age, danish speaking
- allergy to lidocain or amid local analgetics, atrioventricular blok, liver- and/or kidney failure, chronic use of opioids or NSAIDS, pregnancy, breastfeeding women, treatment with betablockers, porphyria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Saline Patients get the same amount in ml and duration as if it was the experimental arm. Only in this arm it is isotonic saline instead. Lidocain Lidocaine Patient gets the experimental treatment with IV lidocain 0,5mg/ml, 1,5mg/kg bolus before induction of anesthesia, after that infusion of 1,5mg/kg/h is started and continued until 2 hours after end of surgery.
- Primary Outcome Measures
Name Time Method Reduction in morphine consumption over the first 24 hours PCA morphine added to PN (per necessitae) morphine, cumulated
- Secondary Outcome Measures
Name Time Method Use of antiemetics postoperative first 72 hours PONV up to 72 hours Postoperative nausea and vomiting - patient is asked
Reduction in morphine consumption over the first 72hours PCA morphine added to PN morphine, cumulated
Time to bowel function first 72 hours time to flatus or defecation or function of bowel stoma
time to discharge up to 72 hours
Trial Locations
- Locations (1)
Odense Universitetshospital
🇩🇰Odense, Denmark